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Dear Editor:
We read with interest the article by Motamedi and col-
leagues about the use of a hand held manometer to mea-
sure strain pressure during Valsalva manoeuvre (VM) treat-
ment of supraventricular tachycardia (SVT) (1). We also used
a manometer in our study (REVERT) of a postural modifica-
tion of the VM and are currently investigating the use of a
simple, single patient use device to control VM strain pres-
sure, NCT number:
NCT03298880 (2, 3). Such a device would be useful as blood
pressure manometers are not always available and cannot be
left with patients and other methods of generating the rec-
ommended strain such as syringes have been shown to be
unreliable (4).
We note that Motamedi’s study demonstrated a cardiover-
sion rate of 14.8% in supine participants, which was similar
to the rate achieved in the REVERT trial by control partici-
pants in the semi recumbent position (17%) (2).
In contrast, participants randomised to the modified VM in
the REVERT trial, had a markedly improved cardioversion
rate of 43% (2). This modification required participants to
perform a 40 mmHg pressure strain for 15 seconds in a semi
recumbent position but with supine repositioning and pas-
sive leg raise immediately after the Valsalva strain. To our
knowledge this is the first trial to study this modification and
was not described in the “new modified version” quoted and
referenced in Motamedi’s paper. To achieve the best car-
dioversion rates, we recommend use of a modified VM as
described above with the strain controlled by a manometer
where possible. A simple, single patient use device designed
to deliver the recommended pressure may be helpful to facil-
itate this in practice and could be kept by patients for future
use (3).
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